The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients
NCT05611684
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
480
Enrollment
OTHER
Sponsor class
Conditions
Type2 Diabetes Mellitus
Interventions
DRUG:
Polyethylene Glycol Losenatide
Sponsor
Nanjing First Hospital, Nanjing Medical University